Overall survival benefits of first-line EGFR tyrosine kinase inhibitors in EGFR-mutated non-small-cell lung cancers: a systematic review and meta-analysis

Feng-Che Kuan; Liang-Tseng Kuo; Min-Chi Chen; Cheng-Ta Yang; Chung-Sheng Shi; David Teng; Kuan-Der Lee

doi:10.1038/bjc.2015.356

Overall survival benefits of first-line EGFR tyrosine kinase inhibitors in EGFR-mutated non-small-cell lung cancers: a systematic review and meta-analysis

British Journal of Cancer ◽

10.1038/bjc.2015.356 ◽

2015 ◽

Vol 113 (10) ◽

pp. 1519-1528 ◽

Cited By ~ 45

Author(s):

Feng-Che Kuan ◽

Liang-Tseng Kuo ◽

Min-Chi Chen ◽

Cheng-Ta Yang ◽

Chung-Sheng Shi ◽

...

Keyword(s):

Systematic Review ◽

Overall Survival ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Lung Cancers ◽

Egfr Tyrosine Kinase Inhibitors ◽

Egfr Mutated

Download Full-text

112P Atezolizumab as first-line therapy for patients with advanced non-small cell lung cancer: A systematic review and meta-analysis on overall survival

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(21)01954-7 ◽

2021 ◽

Vol 16 (4) ◽

pp. S759

Author(s):

E. Marcella ◽

B. Susanto ◽

S. Chen ◽

J. Tandiono ◽

A. Tancherla ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: A systematic review and meta-analysis

Radiotherapy and Oncology ◽

10.1016/j.radonc.2014.12.011 ◽

2015 ◽

Vol 114 (2) ◽

pp. 167-172 ◽

Cited By ~ 55

Author(s):

Yu Yang Soon ◽

Cheng Nang Leong ◽

Wee Yao Koh ◽

Ivan Weng Keong Tham

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Radiation Therapy ◽

Brain Metastases ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitors ◽

Egfr Mutant

Download Full-text

Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR -Mutated Non–Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.2236 ◽

2017 ◽

Vol 12 (4) ◽

pp. 633-643 ◽

Cited By ~ 51

Author(s):

Pei Ni Ding ◽

Sarah J. Lord ◽

Val Gebski ◽

Matthew Links ◽

Victoria Bray ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitors ◽

Risk Of Treatment ◽

Egfr Mutated

Download Full-text

EGFR Tyrosine Kinase Inhibitors Prolong Overall Survival in EGFR Mutated Non-Small-Cell Lung Cancer Patients with Postsurgical Recurrence

Journal of Cancer Research Updates ◽

10.6000/1929-2279.2012.01.01.15 ◽

2012 ◽

Author(s):

Mitsudomi

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Tyrosine Kinase Inhibitors ◽

Postsurgical Recurrence ◽

Egfr Mutated

Download Full-text

Impact of Local Therapy on Disease Progression and Survival Outcomes in Oligometastatic Epidermal Growth Factor Receptor (EGFR) Mutated Non-Small Cell Lung Cancer (NSCLC) Treated with First Line EGFR Tyrosine Kinase Inhibitors (Tkis)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.1326 ◽

2020 ◽

Vol 108 (3) ◽

pp. e152

Author(s):

Y.Y. Soon ◽

C.C. Lee ◽

W.Y. Koh ◽

C.N. Leong ◽

J. Tey

Keyword(s):

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Local Therapy ◽

Small Cell ◽

Survival Outcomes ◽

Small Cell Lung ◽

First Line ◽

Egfr Tyrosine Kinase Inhibitors ◽

Epidermal Growth ◽

Egfr Mutated

Download Full-text

Erratum to: Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-014-1825-x ◽

2014 ◽

Vol 140 (11) ◽

pp. 1911-1911 ◽

Cited By ~ 1

Author(s):

Huan Wang ◽

Jing Huang ◽

Xiaojin Yu ◽

Shuhua Han ◽

Xing Yan ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitors ◽

Egfr Mutated

Download Full-text

Progression patterns after EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutated (EGFR-mut+) non small cell lung cancers (NSCLCs): Correlations with clinical oucomes.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e20600 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e20600-e20600

Author(s):

Alessandro Russo ◽

Valeria Smiroldo ◽

Fabio Raiti ◽

Tindara Franchina ◽

Giuseppa Ferraro ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancers ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors ◽

Egfr Mutated ◽

Progression Patterns

Download Full-text

Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR-Mutated Advanced Non–Small-Cell Lung Cancer Patients Treated With First-Line EGFR Tyrosine Kinase Inhibitors

Clinical Lung Cancer ◽

10.1016/j.cllc.2018.11.014 ◽

2019 ◽

Vol 20 (2) ◽

pp. 124-133.e2 ◽

Cited By ~ 1

Author(s):

Tao Jiang ◽

Jing Zhao ◽

Chao Zhao ◽

Xuefei Li ◽

Jiqiao Shen ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitors ◽

Small Cell ◽

Dynamic Monitoring ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients ◽

Egfr Tyrosine Kinase Inhibitors ◽

Egfr Mutated

Download Full-text

Impact of Programmed Death-Ligand 1 (PD-L1) Expression on The Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKI) in Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.1292 ◽

2020 ◽

Vol 108 (3) ◽

pp. e137

Author(s):

C.C. Lee ◽

Y.Y. Soon ◽

C.N. Leong ◽

W.Y. Koh ◽

J. Tey

Keyword(s):

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Programmed Death Ligand 1 ◽

Programmed Death ◽

Egfr Tyrosine Kinase Inhibitors ◽

Epidermal Growth ◽

Egfr Mutated

Download Full-text

Efficacy of EGFR Tyrosine Kinase Inhibitors in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer: A Meta-Analysis of 13 Randomized Trials

Clinical Lung Cancer ◽

10.1016/j.cllc.2011.08.005 ◽

2012 ◽

Vol 13 (2) ◽

pp. 107-114 ◽

Cited By ~ 76

Author(s):

Fausto Petrelli ◽

Karen Borgonovo ◽

Mary Cabiddu ◽

Sandro Barni

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Randomized Trials ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitors ◽

Egfr Mutated

Download Full-text